HealthQuill Russia
The UN, facing a funding crisis following global budget cuts, is at risk of eroding its credibility and capacity to fulfil the mandates entrusted to it by its 193 members, delegates heard.
Drugs Health Medical

UN’s funding crisis risks credibility, capacity to meet global mandates

HQ Team May 20, 2025: The UN, facing a funding crisis following global budget cuts, is at risk of eroding its credibility and.

Read More
Moderna, a US-based biotechnology company, hopeful of cancer vaccine by 2030
Drugs Pharma

Russia announces free cancer vaccine for citizens by 2025

HQ Team December 18, 2025: Russia recently announced the development of a cancer vaccine, which is expected to be available for distribution free.

Read More
A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from human activities such as fossil fuels, agriculture and landfills, researchers find.
Climate Health Pharma

Global goal to cut methane emissions as distant as a ‘desert oasis’

A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from.

Read More
The world’s tropics lost 4.1 million hectares of forests, the equivalent of 11 soccer fields, every minute in 2022, according to the World Resources Institute.
Climate Health Pharma

Forest cover, the size of 11 football fields, vanishes every minute: WRI

The world’s tropics lost 4.1 million hectares of forests, the equivalent of 11 soccer fields, every minute in 2022, according to the World.

Read More
Europe’s largest nuclear plant, the Zaporizhzhya Nuclear Power Plant, in Ukraine, remains “extremely fragile and dangerous” because the war with Russia may escalate, the IAEA has stated.
Climate Health Medical Pharma

Situation in Europe’s largest nuclear plant remains ‘dangerous’: IAEA 

Europe’s largest nuclear plant, the Zaporizhzhya Nuclear Power Plant, in Ukraine, remains “extremely fragile and dangerous” because the war with Russia may escalate,.

Read More
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near termâ€™ïżŒ

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Read More